GenSight Biologics brings 2 presentations to BPI 2026 in Boston. Its sessions centre on gene therapy approval and on cell and gene therapy roundtables in the exhibit hall. One covers strategies for a streamlined path to BLA success for a gene therapy.
| Organization | BPI 2026 Attendance |
|---|---|
GenSight Biologics Paris, France | 1 Chief Technology Officer |
Developer of gene therapies for retinal neurodegenerative diseases such as Leber hereditary optic neuropathy. | Talk Wed Sep 23 5:00pm–5:45pm Panel Fri Sep 25 9:00am–10:00am |
Instantly find 20 buyers from GenSight Biologics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction